Bottom line
RYJSX vs RYWBX: the short answer
RYJSX (Japan 2x Strategy Fund) and RYWBX (Weakening Dollar 2x Strategy Fund) are both mutual funds.
RYJSX is cheaper at 1.54% vs 1.93% — a difference of $39 a year per $10,000 invested.
Over five years, RYJSX returned −0.7% a year vs −5.8% for RYWBX.
RYJSX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYJSX vs RYWBX side by side
| RYJSX | RYWBX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Guggenheim |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.54% | 1.93% |
| Annual cost per $10k | $154 | $193 |
| 10-yr cost on $10k (prospectus) | $2,270 | $2,351 |
| Max front load | 4.75% | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +43.6% | +19.1% |
| 5-yr return (annualized) | −0.7% | −5.8% |
| 10-yr return (annualized) | +9.1% | −3.0% |
| Best quarter | — | +16.3% |
| Worst quarter | — | −14.0% |
| Net assets (fund) | $3.8M | $899.7K |
| Number of holdings | 5 | 4 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of RYJSX's top 5 holdings also appear in RYWBX's top 4.
| Holding | RYJSX | RYWBX |
|---|---|---|
| J.p. Morgan Securities Llc | 35.05% | 47.49% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 35.05% | 47.48% |
Source: SEC Form N-PORT
RYJSX top 10
- J.p. Morgan Securities Llc — 35.05%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 35.05%
- Chicago Mercantile Exchange — 9.65%
- Chicago Mercantile Exchange — 4.06%
- Chicago Mercantile Exchange — -2.47%
RYWBX top 10
- J.p. Morgan Securities Llc — 47.49%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 47.48%
- Goldman Sachs & Co. Llc — -0.27%
- Ice Futures U.s. — -2.32%
FAQ
What is the difference between RYJSX and RYWBX?
Which is cheaper, RYJSX or RYWBX?
Should I own both RYJSX and RYWBX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.